Accelerating Research and Development of Next Generation Malaria Vaccines Against Malaria – A Model for Mosquito-Borne Diseases
Grant Opportunity Analysis
The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, seeks to support basic research, discovery, and preclinical development of highly efficacious vaccines for malaria and potentially other mosquito-borne illnesses. The program emphasizes novel vaccine design approaches, including structure-based immunogen design and combination vaccines, to reduce parasite infection and malaria disease burden. It is a discretionary federal grant with no matching requirement and is open to a broad range of applicants, including certain tribal governments, federal agencies, U.S. territories, faith-based and community-based organizations, regional organizations, and non-domestic entities. The opportunity is associated with CFDA 93.855, with an estimated synopsis posting date of November 27, 2026, an estimated close date of February 11, 2027, and an estimated award and project start date of December 1, 2027; questions may be sent by email to MalariaandOtherMosquitoBorneDiseases@mail.nih.gov.
Eligible Applicants
Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).